New Positions
0 managers initiated
Top five by reported value
No new institutional positions this quarter.
Universe Pharmaceuticals Inc NASDAQ NMS - GLOBAL MARKET:UPC
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
0 new1 added0 reduced1 exited
Total Institutional Holders
1
as of 2025-12-31
Top Holder
UBS Group AG
$3.6K
Largest QoQ Increase
UBS Group AG
+945 sh
Largest QoQ Decrease
ADVISOR GROUP HOLDINGS, INC.
-2,000 sh
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| UBS Group AG | 946 | +945 | $3.6K | +$3.6K | 94500.0% |
Sold Out(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 0 | -2,000 | $0 | -$9.0K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| UBS Group AG | 946 | $3.6K | +945 | 94500.0% |
New & Closed Positions this quarter
Closed Positions
1 managers exited
Top five by prior-quarter value
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for UPC against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.